argenx SE | Investor Presentation Deck | 23 slides

argenx · 2023-02
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

23
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · What Is
02
other
Open slide detailBeat · What Is
03
The slide uses a thematic background with a network/molecular graphic overlay.establish_context
Open slide detailBeat · What Is
04
The slide uses a circular graphic element to emphasize the 'revolution' in autoimmunity.establish_context
Open slide detailBeat · What IsLoop · Golden Circle
05
present_solution
Open slide detailBeat · What IsLoop · Golden Circle
06
The slide uses a circular cluster diagram to represent the four pillars surrounding the central company vision.summarize
Open slide detailBeat · What IsLoop · Golden Circle
07
The slide uses a waterfall-style bar chart to show quarterly revenue growth throughout the first year of product launch.summarize
Open slide detailBeat · What IsLoop · Golden Circle
08
The slide uses two line charts to compare clinical outcomes. Bottom row features logos of medical journals/societies.analyze_data
Open slide detailBeat · What Could Be
09
Includes a 3-step mechanism of action diagram.summarize
Open slide detailBeat · What Could Be
10
The slide uses a circular cluster diagram to represent four strategic pillars.summarize
Open slide detailBeat · What Could BeLoop · Cost Of Inaction
11
The slide uses a hub-and-spoke style layout to categorize strategic initiatives under two main pillars.present_solution
Open slide detailBeat · New BlissLoop · Cost Of Inaction
12
The slide uses a hub-and-spoke visual metaphor to connect the 'Pioneer FcRn class of medicines' to a list of specific autoantibodies.present_framework
Open slide detailBeat · New BlissLoop · Cost Of Inaction
13
The slide uses a pyramid layout to represent market size, with smaller patient populations at the top and larger ones at the bottom.size_opportunity
Open slide detailBeat · New BlissLoop · Cost Of Inaction
14
The slide uses a timeline-based layout to map clinical development stages (Late Stage vs Proof-of-Concept) against expected data readout years (2023, 2024, 2025plan_implementation
Open slide detailBeat · New BlissLoop · Cost Of Inaction
15
The slide highlights the mechanism of action (sweeping antibody) and the clinical pipeline strategy for ARGX-117.present_solution
Open slide detailBeat · New BlissLoop · Quick Win Big Bet
16
Includes immunofluorescence microscopy images and bar charts/traces for tidal volume and respiratory rate.analyze_data
Open slide detailBeat · New BlissLoop · Quick Win Big Bet
17
The slide uses a process diagram to show the progression from healthy volunteer studies to patient trials.plan_implementation
Open slide detailBeat · New BlissLoop · Quick Win Big Bet
18
The slide uses a circular diagram to represent four distinct business segments.summarize
Open slide detailBeat · New BlissLoop · Quick Win Big Bet
19
The slide uses a network-like background to suggest connectivity between the entities shown.establish_context
Open slide detailBeat · New BlissLoop · Quick Win Big Bet
20
The slide uses a timeline-like structure to map specific drug development and commercialization events to their expected quarters in 2023.plan_implementation
Open slide detailBeat · New BlissLoop · Quick Win Big Bet
21
The diagram features five core values: Co-Creation, Empowerment, Excellence, Humility, and Innovation.summarize
Open slide detailBeat · New Bliss
22
The chart uses a horizontal bar format to represent clinical development stages (Preclinical to Commercial) for multiple indications under three main programs (plan_implementation
Open slide detailBeat · New Bliss
23
The slide outlines a multi-stage clinical trial process including patient identification, open-label, and placebo-controlled phases.present_framework
Open slide detailBeat · New Bliss